Metformin 500mg + Teneligliptin 2.5mg


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Side effects of Tlenta Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Tlenta Diarrhea Nausea Vomiting Hypoglycemia (low blood glucose level)Decreased appetite Abdominal bloating Flatulence Constipation
How to use Tlenta Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Tlenta Duo 500mg/2.5mg Tablet is to be taken with food.
How Tlenta Tablet works Tlenta Duo 500mg/2.5mg Tablet is a combination of two antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Tlenta Duo 500mg/2.5mg Tablet as it is deemed unsafe.
Information regarding the use of Tlenta Duo 500mg/2.5mg Tablet during pregnancy is not available. Doctor consultation is advised.
Information regarding the use of Tlenta Duo 500mg/2.5mg Tablet during breastfeeding is not available. Doctor consultation is advised.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Tlenta Duo 500mg/2.5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Tlenta Duo 500mg/2.5mg Tablet may be needed. Doctor consultation is advised.Use of Tlenta Duo 500mg/2.5mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Tlenta Duo 500mg/2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Tlenta Duo 500mg/2.5mg Tablet may be needed. Doctor consultation is advised.Tlenta Duo 500mg/2.5mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Kishimoto M. Teneligliptin: A DPP-4 inhibitor for the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 2013;6:187-95 (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin Hydrochloride ER (28th Sept. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.